Title |
Immunological evasion of immediate-early varicella zoster virus proteins
|
---|---|
Published in |
Immunogenetics, March 2016
|
DOI | 10.1007/s00251-016-0911-4 |
Pubmed ID | |
Authors |
Pieter Meysman, Dmitry Fedorov, Viggo Van Tendeloo, Benson Ogunjimi, Kris Laukens |
Abstract |
The varicella zoster virus (VZV) causes the childhood disease commonly known as chickenpox and can later in life reactivate as herpes zoster. The adaptive immune system is known to play an important role in suppressing VZV reactivation. A central aspect of this system is the presentation of VZV-derived peptides by the major histocompatibility complex (MHC) proteins. Here, we investigate if key VZV proteins have evolved their amino acid sequence to avoid presentation by MHC based on predictive models of MHC-peptide affinity. This study shows that the immediate-early proteins of all characterized VZV strains are profoundly depleted for high-affinity MHC-I-restricted epitopes. The same depletion can be found in its closest animal analog, the simian varicella virus. Further orthology analysis towards other herpes viruses suggests that the protein amino acid frequency is one of the primary drivers of targeted epitope depletion. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Belgium | 4 | 80% |
United States | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Belgium | 1 | 6% |
Unknown | 16 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 3 | 18% |
Researcher | 3 | 18% |
Student > Ph. D. Student | 3 | 18% |
Other | 1 | 6% |
Lecturer | 1 | 6% |
Other | 3 | 18% |
Unknown | 3 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 24% |
Agricultural and Biological Sciences | 4 | 24% |
Immunology and Microbiology | 2 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Economics, Econometrics and Finance | 1 | 6% |
Other | 1 | 6% |
Unknown | 4 | 24% |